The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: Should we move back?

Oncology (Switzerland)

Volumn 84, Issue 3, 2013, Pages 174-185

  Denaro, N ^a,b   Russi, E G ^c   Numico, G ^e   Pazzaia, T ^f   Vitiello, R ^d   Merlano, M C ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b AOU S Croce e Carle   (Italy)

^c Radiation Oncology ^*  (United States)

^d ENT Surgery   (Italy)

^e Aosta Hospital   (Italy)

^f Savigliano Hospital   (Italy)

Author keywords

Conservative approach; Head and neck cancer; Neck dissection; Postoperative surgery; Primary chemoradiation

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; ARTICLE; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM, RESIDUAL; PROGNOSIS;

EID: 84872063072     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000346132     Document Type: Article

References (73)

1. Lefebvre JL, Ang KK; Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations -a consensus panel summary. Int J Radiat Oncol Biol Phys 2009; 73: 1293-1303.
2. Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1418-1423. (Pubitemid 38438302)
3. Ganly I, Bocker J, Carlson DL, D'Arpa S, Coleman M, Lee N, Pfister DG, Shah JP, Patel SG: Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome. Head Neck 2011; 33: 1387-1393.
4. Lavertu P, Aldestein DJ, Saxton JP, et al: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997; 19: 559-566. (Pubitemid 27407309)
5. Sewall GK, Palazzi-Churas KL, Richards GM, et al: Planned postradiotherapy neck dissection: rationale and clinical outcomes. Laryngoscope 2007; 117: 121-128. (Pubitemid 46074930)
6. Brown KM, Lango M, Ridge JA: The role of neck dissection in the combined modality therapy setting. Semin Oncol 2008; 35: 229-235. (Pubitemid 351787695)
7. Barkley HT Jr, Fletcher GH, Jesse RH, et al: Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972; 124: 462-467.
8. Yao M, Hoffman HT, Chang K, et al: Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Int J Radiat Oncol Biol Phys 2007; 68: 707-713. (Pubitemid 46818743)
9. Corry J, Smith JG, Peters LJ: The concept of a planned neck dissection is obsolete. Cancer J 2001; 7: 472-474. (Pubitemid 41710839)
10. Mendenhall WM, Million RR, Cassisi NJ: Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986; 12: 733-740. (Pubitemid 16033470)
11. Boyd TS, Harari PM, Tannehill SP, et al: Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998; 20: 132-137. (Pubitemid 28106225)
12. Roy S, Tibesar RJ, Daly K, et al: Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy. Head Neck 2002; 24: 474-481. (Pubitemid 34506708)
13. Velazquez RA, McGuff HS, Sycamore D, Miller FR: The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004; 130: 74-77. (Pubitemid 38095433)
14. Mancuso AA, Maceri D, Rice D, Hanafee W: CT of cervical lymph node cancer. AJR Am J Roentgenol 1981; 136: 381-385. (Pubitemid 11136852)
15. Ojiri H, Mancuso AA, Mendenhall WM, Stringer SP: Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol 2002; 23: 1627-1631. (Pubitemid 35304091)
16. Inohara H, Enomoto K, Tomiyama Y, et al: The role of CT and 18 F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol 2008; 7: 1-7.
17. Tan A, Adelstein DJ, Rybicki LA, et al: Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2007; 133: 435-440. (Pubitemid 46799778)
18. Yao M, Graham MM, Hoffman HT, et al: The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004; 59: 1001-1010. (Pubitemid 38834292)
19. Isles MG, McConkey C, Mehanna HM: A systematic review and meta-analysis of the role of positron emission tomography in the follow-up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008; 33: 210-222. (Pubitemid 351799005)
20. Pingarron P, Antonio J, Martin C, Nieves M, Bolton D, Carlos R, Pérez F, Cristina P, Delgado C, Luis J, Yurrita S: Systematic review and meta-analysis of diagnostic accuracy of 18. F-FDG PET in suspected recurrent head and neck cancer (in Spanish). Acta Otorrinolaringol Esp 2008; 59: 190-113.
21. Rogers JW, Greven KM, McGuirt WF, et al: Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy. Int J Radiat Oncol Biol Phys 2004; 58: 694-697. (Pubitemid 38221123)
22. Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA: Revisiting the role of positron-emission tomography/ computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope 2009; 119: 2150-2155.
23. Greven KM, Williams DW, McGuirt WF, et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001; 23: 942-946. (Pubitemid 32977536)
24. Inokuchi H, Kodairat, Tachibana H, Nakamurat, Tomita TN, Nakahara R, Takada A, Mizoguchi N, Tamaki T, Fuwa N: Clinical usefulness of [(18)F] fluoro-2-deoxy-D -glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Int J Radiat Oncol Biol Phys 2011; 79: 747-755.
25. Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R: Diffusionweighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 1098-1107.
26. Newkirk KA, Cullen KJ, Harter KW, Picken CA, Sessions RB, Davidson BJ: Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 2001; 23: 73-79. (Pubitemid 32060658)
27. Igidbashian L, Fortin B, Guertin L, Soulieres D, Coulombe G, Belair M, Charpentier D, Tabet J-C, Nguyen-Tan PF: Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma. Int J Radiation Oncology Biol Phys 2010; 77: 414-420.
28. Grabenbauer GG, Rödel C, Ernst-Stecken A, Brunner T, Hornung J, Kittel K, Steinhart H, Iro H, Sauer R, Schultze-Mosgau S: Neck dissection following radiochemotherapy of advanced head and neck cancer -for selected cases only? Radiother Oncol 2003; 66: 57-56.
29. Koch WM, Lee DJ, Eisele DW, Miller D, Poole M, Cummings CW, Forastiere A: Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995; 121: 974-980.
30. Dagum P, Pinto HA, Newman JP, Higgins JP, Terris DJ, Goffinet DR, Fee WE Jr: Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 1998; 176: 448-452. (Pubitemid 29021545)
31. Sabatini PR, Ducic Y: Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer. Otolaryngol Head Neck Surg 2009; 141: 474-477.
32. Cannady SB, Lee WT, Scharpf J, Lorenz RR, Wood BG, Strome M, Lavertu P, Esclamado RM, Saxton JP, Adelstein DJ: Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck 2010; 32: 348-356.
33. Cho AH, Shah S, Ampil F, Bhartur S, Nathan CO: N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection? Arch Otolaryngol Head Neck Surg 2009; 135: 1112-1118.
34. Loyo M, Johnson JT, Westra WH, Chiosea SI, Gourin CG: Management of the 'violated neck' in the era of chemoradiation. Laryngoscope 2011; 121: 2349-2358.
35. Lau H, Phan T, Mackinnon J, Matthews TW: Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2008; 134: 257-261. (Pubitemid 351439251)
36. Rengan R, Pfister DG, Lee NY, Kraus DH, Shah JP, Shaha AR, Ben-Porat LS, Zelefsky MJ: Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol 2008; 31: 465-469.
37. Vedrine PO, Thariat J, Hitier M, Janot F, Kaminsky MC, Makeieff M, De Raucourt D, Lapeyre M, Toussaint B, French Groupe d'Etude des Tumeurs de la Tete et du Cou Group: Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 2008; 118: 1775-1780.
38. Moukarbel RV, Fung K, Venkatesan V, Franklin JH, Pavamani S, Hammond A, Read N, Yoo JH: The N3 neck: outcomes following primary chemoradiotherapy. J Otolaryngol Head Neck Surg 2011; 40: 137-142.
39. Huang S, Goldstein D, Weinreb I, Perez-Ordonez B, Fung S, Irish J, Waldron J, Kim J, Cummings B, O'Sullivan B: Positive postradiotherapy planned neck dissection is strongly associated with increased distant metastasis rather than regional relapse. Int J Radiat Oncol Biol Phys 2010; 78(suppl 1): S454-S455.
40. Argiris A, Stenson KM, Brockstein BE, et al: Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004; 26: 447-455. (Pubitemid 38569204)
41. Wee JT, Anderson BO, Corry J, D'Cruz A, Soo KC, Qian CN, Chua DT, Hicks RJ, Goh CH, Khoo JB, Ong SC, Forastiere AA, Chan AT: Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009; 10: 1086-1092.
42. Rabalais A, Walvekar RR, Johnson JT, Smith KJ: A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy. Laryngoscope 2012; 122: 311-314.
43. Hamoir M, Leemans R, Dolivet G, Schmitz S, Gregoire V, Andry G: Selective neck dissection in the management of the neck after (chemo) radiotherapy for advanced head and neck cancer. Proposal for a classification update. Head Neck 2010; 32: 816-819.
44. Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA: Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck 2009;31:328-337.
45. Javidnia H, Corsten MJ: Number needed to treat analysis for planned neck dissection after chemoradiotherapy for advanced neck disease. J Otolaryngol Head Neck Surg 2010; 39: 664.
46. Ebrahimi A, Zhang WJ, Gao K, Clark JR: Nodal yield and survival in oral squamous cancer. Cancer 2011; 117: 2917-2925.
47. Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA, Committee for Neck Dissection Classification, American Head and Neck Society: Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008; 134: 536-538. (Pubitemid 351724386)
48. Yeung AR, Liauw SL, Amdur RJ, Mancuso AA, Hinerman RW, Morris CG, Villaret DB, Werning JW, Mendenhall WM: Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer 2008; 112: 1076-1082. (Pubitemid 351304592)
49. Doweck I, Robbins KT, Mendenhall WM, et al: Neck level-specific nodal metastases in oropharyngeal cancer: is there any role for selective neck dissection after definitive radiotherapy? Head Neck 2003; 25: 960-967. (Pubitemid 37336437)
50. Dhiwakar M, Robbins KT, Vieira F, Rao K, Malone J: Selective neck dissection as an early salvage intervention for clinically persistent nodal disease following chemoradiation. Head Neck 2012; 34: 188-193.
51. Clayman GL, Johnson CJ II, Morrison W, et al: The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001; 127: 135-139. (Pubitemid 32163638)
52. Naiboǧlu B, Karapinar U, Agrawal A, Schuller DE, Ozer E: When to manage level V in head and neck carcinoma? Laryngoscope 2011; 121: 545-547.
53. Goguen LA, Posner MR, Tishler RB, et al: Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006; 132: 526-531. (Pubitemid 43742571)
54. Chan AW, Ancukiewicz M, Carballo N, et al: The role of postradiotherapy neck dissection in supraglottic carcinoma. Int J Radiat Oncol Biol Phys 2001; 50: 367-375. (Pubitemid 32472265)
55. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
56. Takes R: Gene expression signature for distinguishing tumours metastasizing to regional lymph nodes. 3rd ICHNO, 2011.
57. Liauw SL, Mancuso AA, Amdur RJ, Morris CG, Villaret DB, Werning JW, Mendenhall WM: Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 2006; 24: 1421-1427. (Pubitemid 46622008)
58. Corry J, Peters L, Fisher R, Macann A, Jackson M, McClure B, et al: N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders -results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 2008; 30: 737-742. (Pubitemid 351913849)
59. Porceddu SV, Pryor DI, Burmeister E, Burmeister BH, Poulsen MG, Foote MC, et al: Results of a prospective study of positron emission tomography -directed management of residual nodal abnormalities in node positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011; 33: 1675-1682.
60. Thariat J, Ang KK, Allen PK, Ahamad A, Williams MD, Myers JN, et al: Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82:e367-e374.
61. McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Posner MR, Van den Abbeele AD: Positron emission tomography with 18 F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 2004; 26: 890-896. (Pubitemid 39299309)
62. Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA: The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006; 116: 855-858. (Pubitemid 44317978)
63. Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, Graham MM, Buatti JM: Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of headand-neck cancer -a long-term outcome report. Int J Radiat Oncol Biol Phys 2009; 74: 9-14.
64. Ong SC, Schöder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH: Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49: 532-540. (Pubitemid 351520600)
65. Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Grégoire V: Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 2010; 28: 1190-1195.
66. Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H: Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010; 31: 262-268.
67. LeFebvre J-L: 5th European Conference on Head and Neck Oncology 18-21 April 2012. Eur Arch Otorhinolaryngol 2012; 269: 1311-1410.
68. Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA: Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006; 24: 1064-1071. (Pubitemid 46638803)
69. Righini CA, Nadour K, Faure C, Rtail R, Morel N, Beneyton V, Reyt E: Salvage surgery after radiotherapy for oropharyngeal cancer. Treatment complications and oncological results. Eur Ann Otorhinolaryngol Head Neck Dis 2012; 129: 11-16.
70. Malone J, Robbins KT: Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 89-94.
71. Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A: Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck 2010; 32: 253-261.
72. Da Mosto MC, Lupato V, Romeo S, Spinato G, Addonisio G, Baggio V, Gava A, Boscolo-Rizzo P: Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease? Ann Surg Oncol 2012, E-pub ahead of print.
73. Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT: A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 994-999.